CHINA: Innovative Development Plan of Introducing Drug and Medical devices in Guangdong, Hong Kong, Macao and the Greater Bay Area
- 2021-01-19 02:48:31
China National Medical Product Administration (NMPA) has revised the special approval procedures for innovative medical devices issued in 2014 to respond to current state. This revision will be effective on December 1, 2018.
MoreChina National Drug Administration (CNDA) has revised the special approval procedures for innovative medical devices issued in 2014 to respond to current state. Drafts of the revision were released in early May and is currently open for public comments. This revision will be expected to take effect on October 1, 2018.
MoreWir verwenden Cookies, um Ihnen ein optimales Website-Erlebnis zu bieten und um die Zugriffe auf unserer Internetseite analysieren zu können. Klicken Sie auf "Ich stimme zu", um Cookies zu akzeptieren und direkt zur Website weiter zu navigieren.